This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Daewoong Pharmaceutical Co., Ltd.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: The Innovations of Han-Kuk Lee
Introduction
Han-Kuk Lee is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for crystallizing isomers of important compounds. His work is characterized by a focus on enhancing the efficiency and effectiveness of pharmaceutical formulations.
Latest Patents
Han-Kuk Lee holds a patent for a method for selectively crystallizing a Z isomer of iopromide. This invention involves a process that includes dissolving a crude iopromide mixture in an alcohol and subsequently heating the solution to obtain crystalline Z isomer of iopromide. This innovative method not only improves the purity of the Z isomer but also facilitates the preparation of compositions that include this crystalline form.
Career Highlights
Lee is currently associated with Daewoong Pharmaceutical Co., Ltd., a leading pharmaceutical company in South Korea. His work at Daewoong has allowed him to contribute to various projects aimed at improving drug formulations and delivery systems. His expertise in crystallization techniques has been instrumental in advancing the company's research and development efforts.
Collaborations
Han-Kuk Lee has collaborated with several talented individuals in his field, including Soo-Jin Choi and Byung-Goo Lee. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical methods and products.
Conclusion
Han-Kuk Lee's contributions to the field of pharmaceuticals through his innovative patent and collaborative efforts highlight his role as a key inventor in the industry. His work continues to influence the development of effective pharmaceutical solutions.